Szeremeta, A.; Jura-Półtorak, A.; Grim, A.; Kuźnik-Trocha, K.; Olczyk, P.; Ivanova, D.; Kiselova-Kaneva, Y.; Olczyk, K.; Komosińska-Vassev, K.
Changes in Urinary NGAL, FN, and LN Excretion in Type 2 Diabetic Patients Following Anti-Diabetic Therapy with Metformin. J. Clin. Med. 2025, 14, 1088.
https://doi.org/10.3390/jcm14041088
AMA Style
Szeremeta A, Jura-Półtorak A, Grim A, Kuźnik-Trocha K, Olczyk P, Ivanova D, Kiselova-Kaneva Y, Olczyk K, Komosińska-Vassev K.
Changes in Urinary NGAL, FN, and LN Excretion in Type 2 Diabetic Patients Following Anti-Diabetic Therapy with Metformin. Journal of Clinical Medicine. 2025; 14(4):1088.
https://doi.org/10.3390/jcm14041088
Chicago/Turabian Style
Szeremeta, Anna, Agnieszka Jura-Półtorak, Alicja Grim, Kornelia Kuźnik-Trocha, Paweł Olczyk, Diana Ivanova, Yoana Kiselova-Kaneva, Krystyna Olczyk, and Katarzyna Komosińska-Vassev.
2025. "Changes in Urinary NGAL, FN, and LN Excretion in Type 2 Diabetic Patients Following Anti-Diabetic Therapy with Metformin" Journal of Clinical Medicine 14, no. 4: 1088.
https://doi.org/10.3390/jcm14041088
APA Style
Szeremeta, A., Jura-Półtorak, A., Grim, A., Kuźnik-Trocha, K., Olczyk, P., Ivanova, D., Kiselova-Kaneva, Y., Olczyk, K., & Komosińska-Vassev, K.
(2025). Changes in Urinary NGAL, FN, and LN Excretion in Type 2 Diabetic Patients Following Anti-Diabetic Therapy with Metformin. Journal of Clinical Medicine, 14(4), 1088.
https://doi.org/10.3390/jcm14041088
